297 related articles for article (PubMed ID: 15781626)
1. Cytoplasmic HuR expression is a prognostic factor in invasive ductal breast carcinoma.
Heinonen M; Bono P; Narko K; Chang SH; Lundin J; Joensuu H; Furneaux H; Hla T; Haglund C; Ristimäki A
Cancer Res; 2005 Mar; 65(6):2157-61. PubMed ID: 15781626
[TBL] [Abstract][Full Text] [Related]
2. Prognostic role of HuR in hereditary breast cancer.
Heinonen M; Fagerholm R; Aaltonen K; Kilpivaara O; Aittomäki K; Blomqvist C; Heikkilä P; Haglund C; Nevanlinna H; Ristimäki A
Clin Cancer Res; 2007 Dec; 13(23):6959-63. PubMed ID: 18056170
[TBL] [Abstract][Full Text] [Related]
3. Expression of HuR is associated with increased cyclooxygenase-2 expression in uterine cervical carcinoma.
Lim SJ; Kim HJ; Kim JY; Park K; Lee CM
Int J Gynecol Pathol; 2007 Jul; 26(3):229-34. PubMed ID: 17581403
[TBL] [Abstract][Full Text] [Related]
4. Cyclooxygenase-2 is an independent prognostic factor in gastric cancer and its expression is regulated by the messenger RNA stability factor HuR.
Mrena J; Wiksten JP; Thiel A; Kokkola A; Pohjola L; Lundin J; Nordling S; Ristimäki A; Haglund C
Clin Cancer Res; 2005 Oct; 11(20):7362-8. PubMed ID: 16243808
[TBL] [Abstract][Full Text] [Related]
5. HuR expression in the nucleus correlates with high histological grade and poor disease-free survival in ovarian cancer.
Yi X; Zhou Y; Zheng W; Chambers SK
Aust N Z J Obstet Gynaecol; 2009 Feb; 49(1):93-8. PubMed ID: 19281587
[TBL] [Abstract][Full Text] [Related]
6. Expression of the ELAV-like protein HuR is associated with higher tumor grade and increased cyclooxygenase-2 expression in human breast carcinoma.
Denkert C; Weichert W; Winzer KJ; Müller BM; Noske A; Niesporek S; Kristiansen G; Guski H; Dietel M; Hauptmann S
Clin Cancer Res; 2004 Aug; 10(16):5580-6. PubMed ID: 15328200
[TBL] [Abstract][Full Text] [Related]
7. Reduced nuclear expression of transcription factor AP-2 associates with aggressive breast cancer.
Pellikainen J; Kataja V; Ropponen K; Kellokoski J; Pietiläinen T; Böhm J; Eskelinen M; Kosma VM
Clin Cancer Res; 2002 Nov; 8(11):3487-95. PubMed ID: 12429639
[TBL] [Abstract][Full Text] [Related]
8. Expression of the embryonic lethal abnormal vision-like protein HuR in human mesothelioma: association with cyclooxygenase-2 and prognosis.
Stoppoloni D; Cardillo I; Verdina A; Vincenzi B; Menegozzo S; Santini M; Sacchi A; Baldi A; Galati R
Cancer; 2008 Nov; 113(10):2761-9. PubMed ID: 18831511
[TBL] [Abstract][Full Text] [Related]
9. Cytoplasmic HuR over-expression is associated with increased cyclooxygenase-2 expression in laryngeal squamous cell carcinomas.
Cho NP; Han HS; Soh Y; Lee KY; Son HJ
Pathology; 2007 Dec; 39(6):545-50. PubMed ID: 18027256
[TBL] [Abstract][Full Text] [Related]
10. The expression of RNA-binding protein HuR in non-small cell lung cancer correlates with vascular endothelial growth factor-C expression and lymph node metastasis.
Wang J; Zhao W; Guo Y; Zhang B; Xie Q; Xiang D; Gao J; Wang B; Chen Z
Oncology; 2009; 76(6):420-9. PubMed ID: 19420963
[TBL] [Abstract][Full Text] [Related]
11. Metastasis tumor antigen family proteins during breast cancer progression and metastasis in a reliable mouse model for human breast cancer.
Zhang H; Stephens LC; Kumar R
Clin Cancer Res; 2006 Mar; 12(5):1479-86. PubMed ID: 16533771
[TBL] [Abstract][Full Text] [Related]
12. Cytoplasmic HuR expression correlates with epithelial cancer cell but not with stromal cell cyclooxygenase-2 expression in mucinous ovarian carcinoma.
Erkinheimo TL; Sivula A; Lassus H; Heinonen M; Furneaux H; Haglund C; Butzow R; Ristimäki A
Gynecol Oncol; 2005 Oct; 99(1):14-9. PubMed ID: 16126263
[TBL] [Abstract][Full Text] [Related]
13. Stromal expression of CD10 in invasive breast carcinoma: a new predictor of clinical outcome.
Iwaya K; Ogawa H; Izumi M; Kuroda M; Mukai K
Virchows Arch; 2002 Jun; 440(6):589-93. PubMed ID: 12070597
[TBL] [Abstract][Full Text] [Related]
14. Activated Akt signaling pathway in invasive ductal carcinoma of the breast: correlation with HER2 overexpression.
Park SS; Kim SW
Oncol Rep; 2007 Jul; 18(1):139-43. PubMed ID: 17549359
[TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of cytoplasmic SOX9 in invasive ductal carcinoma and metastatic breast cancer.
Chakravarty G; Moroz K; Makridakis NM; Lloyd SA; Galvez SE; Canavello PR; Lacey MR; Agrawal K; Mondal D
Exp Biol Med (Maywood); 2011 Feb; 236(2):145-55. PubMed ID: 21321311
[TBL] [Abstract][Full Text] [Related]
16. CD24 expression has a prognostic impact in breast carcinoma.
Athanassiadou P; Grapsa D; Gonidi M; Athanassiadou AM; Tsipis A; Patsouris E
Pathol Res Pract; 2009; 205(8):524-33. PubMed ID: 19243896
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of elevated cyclooxygenase-2 expression in breast cancer.
Ristimäki A; Sivula A; Lundin J; Lundin M; Salminen T; Haglund C; Joensuu H; Isola J
Cancer Res; 2002 Feb; 62(3):632-5. PubMed ID: 11830510
[TBL] [Abstract][Full Text] [Related]
18. Cytoplasmic localization of beta-catenin is a marker of poor outcome in breast cancer patients.
López-Knowles E; Zardawi SJ; McNeil CM; Millar EK; Crea P; Musgrove EA; Sutherland RL; O'Toole SA
Cancer Epidemiol Biomarkers Prev; 2010 Jan; 19(1):301-9. PubMed ID: 20056651
[TBL] [Abstract][Full Text] [Related]
19. The expression pattern of MUC1 (EMA) is related to tumour characteristics and clinical outcome of invasive ductal breast carcinoma.
van der Vegt B; de Roos MA; Peterse JL; Patriarca C; Hilkens J; de Bock GH; Wesseling J
Histopathology; 2007 Sep; 51(3):322-35. PubMed ID: 17645748
[TBL] [Abstract][Full Text] [Related]
20. CD24 expression in ductal carcinoma in situ and invasive ductal carcinoma of breast: an immunohistochemistry-based pilot study.
Bircan S; Kapucuoglu N; Baspinar S; Inan G; Candir O
Pathol Res Pract; 2006; 202(8):569-76. PubMed ID: 16828238
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
